TrialToxins2026

Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan.

Toshiaki Goseki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.